期刊文献+

Clinical utility of non-invasive tests to predict clinical outcomes in non-alcoholic fatty liver disease

原文传递
导出
摘要 Non-alcoholic fatty liver disease(NAFLD)is the leading cause of chronic liver disease,and the fastest-growing cause of hepatocellular carcinoma(HCC)worldwide(1,2).As the number of people with NAFLD is too great to perform surveillance in all,risk-stratification strategies are increasingly important to identify those at the highest risk of decompensation and HCC(3,4).
出处 《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第6期916-918,共3页 肝胆外科与营养(英文)
基金 support from the Singapore Ministry of Health’s National Medical Research Council (No.MOH-001370 to DQH).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部